This is the final post in our series collecting the great conversations from our June Protection Forum. In this section, attendees discussed PMI, helping advisers sell protection, and putting the focus on rehab and value-added services.
We’ve already got lots of different types of products, and having more versions or hybrid products will just make things more confusing. I think IP should consider treatment or other actions that reduce potential claims as part of claims management.
Ian Sawyer:
Well, as you know, we do quite a fair few PMI sales and there’s been a few diagnostic products, but they sell in very, very small numbers because people’s expectations is that “once I get diagnosed, then I’m really focused on the diagnosis because the waiting is often the worst to find out and then I want the treatment.” And then if the NHS, especially now, is not in a position to do that treatment, and some reports say that we can face ten a ten million waiting list in some ways, I think that would be problematic.
My other point with regards to hybrid products, whilst I get the theory and the theory is sound, in reality, we already have a myriad of different names of products and different types of cover, and the consumers don’t understand them as it is. We’ve got life insurance, we got critical illness cover, we got serious illness cover. We got Key 3 cover. We’ve got health insurance, we’ve got medical insurance, we’ve got accidents, sickness insurance, we’ve got income protection, we’ve got mortgage payment protection, et cetera, et cetera. Having yet another version is going to muddy the waters greatly.
What I think IP insurers should be focused on is if the treatment or any action is going to reduce potential claims then they should be considering that as a part of their claims management. And also, if it is proven that those with PMI who will get faster treatment and a faster diagnosis, those with PMI are therefore potentially a better risk for IP, then why not give them a discount and encourage them to have their PMI covered as well?
I consider PMI the fourth type of protection. This is another opportunity for signposting and partnerships across the community. We need to change IP so it’s fit for purpose for people who have multiple jobs and how people will work going forwards.
Roy McLoughlin:
I’ve always called PMI the fourth protection insurance for years anyway, and when I go and meet clients, I always say that there are four types of protection you can have. But Ian is spot-on, most people don’t understand the differences and therefore it’s really important we present them as a complete solution. The amount of people I’ve met over the years that got PMI who think they’re going to get a pay-out if they have a critical illness, because it’s just basically not been explained to them properly, shutter me. And vice versa it happens as well.
But I think this is yet again a great application for signposting, because I think this is another example of where, and Ian is unusual because he does them all, but where the protection guys should talk to the PMI guys and vice versa and create partnerships with people across the industry so that you can give your clients a comprehensive solution to the whole thing. So I think this is yet another signposting thing. And also, I’ll just jump in and totally agree with what you said, Rob. We need to change IP and make it fit for purpose for people that have got multiple jobs. All the research is telling us going forward that people are going to start having different types of jobs.
And I think many of us advisers are just a bit worried that this isn’t being addressed quick enough and we need to retain the faith in the product. Yes, the sales went down slightly last week with Swiss Re, but I think that can be explained away by they want cover going, but we’re on an upward trajectory here. IP is in a very, very good place. But I think we need to adapt to how people are going to work going forward. And there’s no doubt that particularly, remember, it’s still five and a half million people on furlough, particularly post furlough.
The way people are going to work and the way they’re going to be employed is going to be different. And although the PDG and the IP tab are both for both looking to this at the moment, as many of you on the call to be aware of, we’ve got to get this self-employed situation right so that when people have fluctuating earnings and they don’t have to be self-employed, obviously, but when they have fluctuating earnings, they have absolute surety and faith in the fact that the product is going to adapt with them.
We’ve managed to help a lot of traditional advisers sell private medical insurance. Complexity is something that is often pointed at as an issue, but that’s also where the adviser comes in.
Andy Philo:
I was just going to mention that pretty early on in our evolution in the U.K., we did launch a hybrid type role offering sort of a health and a life product. It wasn’t specifically IP product, but it didn’t really sell. And I think it probably was too early for us really in terms of the market. But it was the cost really and the complexity at that particular time that turned some advisers off.
So what we’ve done is we’ve offered I mean, Andy mentioned it earlier, on sort of a referral type model. But what we’ve successfully done is we’ve managed to convert a lot of traditional sort of advisers into selling private medical insurance. And it’s now our second biggest channel on the health side in terms of a traditional, whatever that means, financial adviser now either referring or selling private medical insurance.
I think the complexity piece is obviously something that gets labelled, particularly at Vitality quite a bit. But I do think I mean, we try not to be complex just for complex sake. But I do think that’s where the adviser really does add value and so, I want to be clear, this is not about us adding complexity just to make it harder for everyone. But this is what differentiates, the adviser, I think, from just going online and a client self-service. And so I really like Roy’s idea of it being the fourth type of product and bundling it in. But, I think there’s definitely a space for it. I think we were a little bit too early, really, in our thinking, and probably the market wasn’t ready for it as well.
It’s not just about giving a claimant money but helping them get back to work.
Clinicians are actually wondering why insurers never ask them for case studies on the benefits of rehab. Recent studies show that a third of unplanned retirement in the UK is a result of health issues and acquired disability and another 8% is having to give up work to care for a partner, which really makes the case for IP as part of an investment portfolio for accumulating funds for retirement.
The two steps to me are creating the material for advisers to use that they actually need, and then figuring out how to make sure they use it.
It’s our responsibility in the industry to tell the stories, and we should be telling more stories about the benefits of value-added services. Journalists have started to change their view on insurance and are much more open to positive stories.





